Addendum to the Lyme disease conf.
in Hull 1-2. Sep. 2001

Pictures of ehrlichia and babesia, shown by Miguel Ramirez Ortega, can be found at:

Ehrlichia (HGE)
Babesia WA1
Babesia canis
Babesia bigemini
Babesia microti



Benezra D, Brown AE, Polsky B, et al.
Babesiosis and infection with human immunodeficiency virus (HIV).
Ann Intern Med 1987;107:904.


Bonoan JT, Johnson DH, Cunha BA.
Life-threatening babesiosis in an asplenic patient treated with exchange transfusion, azithromycin, and atovaquone.
Heart Lung (United States), Nov-Dec 1998, 27(6) p424-8


Boustani M, Gelfand J:
In: Clinical Infectious Diseases 1996; 22: 611-615.


Boustani M, Lepore T:
Acute respiratory failure in patients treated for Babesiosis.
Am J Respir Crit Care Med 1994; 149: 1689-1691.


Brasseur P, Lecoublet S, Kapel N:
Quinine in the treatment of Babesia divergens infections in humans.
Eur J Clin Microbiol Infect Dis 1996; 15: 840-841


Brasseur P, Lecoublet S, Kapel N, et al.
In vitro evaluation of drug susceptibilities of Babesia divergens isolates.
Antimicrob Agents Chemother (United States), Apr 1998, 42(4) p818-20


Cahill KM, Benach JL, Reich LM, et al.
Red cell exchange: treatment of babesiosis in a splenectomized patient.
Transfusion 1981; 21:193-8.


Burrascano J.:
Diagnostic hints and treatment guidelines for lyme and other tick borne illnesses.


Denes E, Rogez JP, Darde ML, et al.
Management of Babesia divergens babesiosis without a complete course of quinine treatment.
Eur J Clin Microbiol Infect Dis (Germany), Sep 1999, 18(9) p672-3


Dorman SE, Cannon ME, Telford SR 3rd, et al.
Fulminant babesiosis treated with clindamycin, quinine, and whole blood exchange transfusion.
Transfusion (United States), Mar 2000, 40(3) p375-80


Evenson DA, Perry E, Kloster B, et al.
Therapeutic apheresis for babesiosis.
J Clin Apheresis (United States), 1998, 13(1) p32-6


Falagas ME. Klempner MS.
Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin.
Clinical Infectious Diseases. 22(5):809-12, 1996 May


Francioli PB, Keithly JS, Jones TC, Brandstetter RD, Wolf DJ.
Response of babesiosis to pentamidine therapy.
Ann Intern Med 1981; 94: 326-30.


Gupta P, Hurley RW, Helseth PH:
Pancytopenia due to hemophagocytic syndrome as the presenting manifestation of babesiosis.
Am J Hematol 1995 Sep; 50(1): 60-2.


Gelfand JA.
In: Mandell GL, Bennett JE, Dolin R, eds.
Mandell, Douglas and Bennett's principles and practice of infectious diseases.
4th ed., Vol 2. New York: Churchill Livingstone, 1995:2497 500


Gorenflot A, Moubri K, Precigout E, Carcy B, Schetters TP.
Human babesiosis.
Ann Trop Med Parasitol (England), Jun 1998, 92(4) p489-501


Herwaldt B, Persing DH, Precigout EA, Goff WL, Mathiesen DA, Taylor PW, Eberhard ML, Gorenflot AF.
A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans.
Ann Intern Med 1996 Apr 1;124(7):643-50


Horowitz M, Coletta F, Fein A:
Delayed onset adult respiratory distress syndrome in Babesiosis.
Chest 1994; 106: 1299-1301.


Horowitz R.:
Mefloquine and Artemesia: A Prospective Trial of Combination Therapy in Chronic Babesiosis.
13th International Scientific Conference on Lyme Disease & Other Tick-Borne Disorders Emphasis: Pediatrics & New Research March 24-26, 2000 Hartford Marriott Farmington, CT, USA


Krause P, Telford S, Pollack R:
Babesiosis: An underdiagnosed disease of children.
Pediatrics 1992; 89: 1045-1048.


Krause P, Telford S, Speilman A:
Concurrent Lyme Disease and Babesiosis: Evidence for increased severity and duration of illness.
JAMA 1996; 275: 1657-1660.


Krause PJ, Telford S RI , Ryan R, et al. 
Diagnosis of babesiosis: Evaluation of a serologic test for the detection of Babesia microti antibody.
1994; J Infect Dis 169:923-926.


Krause PJ, Lepore T, Sikand VK, et al.
Atovaquone and Azithromycin for the Treatment of Babesiosis
N Engl J Med (United States), Nov 16 2000, 343(20) p1454-1458


Krause PJ, Telford S, Spielman A, et al.
Treatment of babesiosis: comparison of atovaquone and azithromycin with clindamycin and quinine.
In: Program and abstracts of the 46th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Lake Buena Vista, Fla., December 7-11, 1997. Northbrook, Ill.: American Society of Tropical Medicine and Hygiene, 1997:247.
abstract Krause et al. JAMA 275:1657-60 (1996); SR Telford III et al. PNAS 93:6209-14 (1996)


Krause PJ, Spielman A, Telford SR 3rd, et al.
Persistent parasitemia after acute babesiosis.
N Engl J Med (United States), Jul 16 1998, 339(3) p160-5


Jacoby GA, Hunt JV, Kosinski KS, et al.
Treatment of transfusion-transmitted babesiosis by exchange transfusion.
N Eng J Med 1980; 303:1098-100.

Lobetti R
Canine babesiosis.
Compendium for Cont. Ed. 20(4) 418 Chapters 28 (Ehrlichiosis) and 77 (Babesiosis) "Infectious Diseases of the Dog and Cat"  2nd ed (1998), WB Saunders.

Marley SE, Eberhard ML, Steurer FJ, et al.
Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model.
Antimicrob Agents Chemother (United States), Jan 1997, 41(1) p91-4


Marsaudon E, Camenen J, Testou D, Bourree P, Samson P, Luneau F
[Babesia canis human babesiosis causing a 40-day anuria].
Ann Med Interne (Paris) 1995;146(6):451-2


Miller LH, Neva FA, and Gill F.
Failure of chloroquine in human babesiosis (Babesia microti): case report and chemotherapeutic trials in hamsters.
Ann Intern Med 1978; 88:200-2.


Perdrizet GA, Olson NH, Krause PJ, et al.
Babesiosis in a renal transplant recipient acquired through blood transfusion.
Transplantation (United States), Jul 15 2000, 70(1) p205-8


Persing DH, Herwaldt BL, Glaser C:
Infection with a babesia-like organism in northern California.
N Engl J Med 1995 Feb 2; 332(5): 298-303.


Piesman J, Spielman A.
Human babesiosis on Nantucket Island: transmission by nymphal Ixodes ticks.
Am J Trop Med Hyg 1986;25:784.


Pruthi RK. Marshall WF. Wiltsie JC. Persing DH.
Human babesiosis.
Mayo Clinic Proceedings.
70(9):853-62, 1995


Quick RE, Herwaldt BL, Thomford JW, Garnett ME, Eberhard ML, Wilson M, Spach DH, Dickerson JW, Telford SR 3rd, Steingart KR, et al.
Babesiosis in Washington State: a new species of Babesia?
Ann Intern Med 1993 Aug 15;119(4):284-90


Raoult D, Soulayrol L, Toga B, et al.
Babesiosis, pentamidine and cotrimazole.
Ann Intern Med 1987;107:944


Rosner F, Zarrabi MH, Benach JL, Habichi GS.
Babesiosis in splenectomized adults: a review of 22 reported cases.
Am J Med 1984; 76:696 701


Rosenbaum GS, Johnson DH, Cunha BA.
Atypical lymphocytosis in babesiosis.
Clin Infect Dis 1995; 20:203-4


Rowin KS, Tanowitz HB, Wittner M.
Therapy of experimental babesiosis.
Ann Intern Med 1982;97:556.


Ruebush TK, 2d, Cassaday PB, Marsh HJ, et al.
Human babesiosis on Nantucket Island: clinical features.
Ann Intern Med 1977; 86:6-9.


Ruebush TK, 2d, Contacos PG, Steck EA.
Chemotherapy of Babesia microti infections in mongolian jirds.
Antimicrob Agents Chemother 1980; 18: 289-91.


Ruebush TK, 2d, Rubin RH, Wolpow ER, Cassady PB, Schultz MG.
Neurologic complications following the treatment of human Babesia microti infection with diminazene aceturate.
Am J Trop Med Hyg 1979; 28: 184-9.


Slovut D, Benedetti E, Mata A:
Babesiosis and hemophagocytic syndrome in an asplenic renal transplant recipient.
Transplantation 1996; 62: 537-545.


Smith T, Kilbourne FL.
Investigation into the nature, causation, and prevention of Texas or south cattle fever.
USDA Industry Bulletin 1893;1:1.


Spielman A, Wilson ML, Levine JF, Piesman J.
Ecology of Ixodes dammini-borne human babesiosis and Lyme disease.
Annual Review of Entomology 1985;30:439.


Weiss LM, Wittner M, Wasserman S, et al.
Efficacy of azithromycin for treating Babesia microti infection in the hamster model.
J Infect Dis 1993;168:1289.


Wittner M, Lederman J, Tanowitz HB, Rosenbaum GS, Weiss LM.
Atovaquone in the treatment of Babesia microti infections in hamsters.
Am J Trop Med Hyg 1996;55:219-22.


Wittner M, Rowin KS, Tanowitz HB, et al.
Successful chemotherapy of transfusion babesiosis.
Ann Intern Med 1982;96:601-4.



Abbott K.
Hemophagocytic Syndrome: A cause of pancytopenia in human ehrlichiosis.
Amer J of Hem 38: 230-234; 1991

Aguero-Rosenfeld M, Horowitz HW, Wormser GP, et al.
Human granulocytic ehrlichiosis a case series from a single medical center in New York State.
Ann Intern Med 1996; 125: 904-8.

Bakken JS, Aguero-Rosenfeld ME, Tilden RL, et al.
Serial Measurements of Hematologic Counts During the Active Phase of Human Granulocytic Ehrlichiosis
Clin Infect Dis. 2001;32:862-870

Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS.
Clinical and laboratory characteristics of human granulocytic ehrlichiosis.
JAMA 1996; 275: 199-205.

Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH.
Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a new species emerging?
JAMA 1994; 272: 212.

Bakken JS, Goellner P, Van Etten M, et al.
Seroprevalence of human granulocytic ehrlichiosis (HGE) and risk factors associated with infection among residents in north-western Wisconsin.
Clin Infect Dis 1998; 27: 1491-96

Bakken JS.
The discovery of human granulocytotropic ehrlichiosis.
J Lab Clin Med. 1998;132:175-180.

Bakken JS, Erlemeyer SA, Kanoff RJ, Silvestrini TC, Goodwin DD, Dumler JS.
Demyelinating polyneuropathy associated with human granulocytic ehrlichiosis.
Clin Infect Dis 1998; 27: 1323-24.

Barton L.
Infection with Ehrlichia in childhood.
J of Ped 120: 998-1001, 1992.

Barenfanger J, Patel PG, Dumler JS, Walker DH.
Identifying human ehrlichiosis.
Lab Med 1996; 27: 372-74.

Bjoersdorff A, Berglund J, Kristiansen BE, Soderstrom C, Eliasson I.
Varying clinical picture and course of human granulocytic ehrlichiosis. Twelve Scandinavian cases of the new tick-borne zoonosis are presented.
Lakartidningen 1999; 96: 4200-04.

Belongia EA, Reed KD, Mitchell PD, et al.
Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin.
Clin Infect Dis 1999; 29: 1472-77.

Brouqui P, Raoult D.
In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis.
Antimicrob Agents Chemother 1992; 36: 2799-803.

Buitrago MI, Ijdo JW, Rinaudo P, et al.
Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin.
Clin Infect Dis 1998; 27: 213-15.

Buller RS, Arens M, Hmiel SP, et al.
Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis.
Engl J Med 1999; 341: 148-55.

Caldwell CW, Everett ED, McDonald G, Yesus YW, Roland WE.
Lymphocytosis of gamma/delta T cells in human ehrlichiosis.
Am J Clin Pathol. 1995 Jun;103(6):761-6.

Carpenter CF, Gandhi TK, Kong LK, et al.
The incidence of ehrlichial and rickettsial infection in patients with unexplained fever and recent history of tick bite in Central North Carolina.
J Infect Dis 1999; 180: 900-03.

Chen S, Dumler JS, Bakken JS, Walker DH.
Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.
J Clin Microbiol 1994; 32: 589.

Chen S-M, Cullman LC, Walker DH.
Western immunoblotting analysis of the antibody responses of patients with human monocytotropic ehrlichiosis to different strains of Ehrlichia chaffeensis and Ehrlichia canis.
Clin Diagn Lab Immunol 1997; 4: 731-35.

Childs JE, Sumner JW, Nicholson WL, Massung RE, Standaert SM, Paddock CD.
Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implication for surveillance.
J Clin Microbiol 1999; 37: 2097-3000.

Dawson JE, Fishbein DB, Eng TR, Redus MA, Green NR.
Diagnosis of human ehrlichiosis with the indirect fluorescent antibody test.
Journ of Inf Dis 1990;162: 91-95

Dumler JS, Asanovich KM, Bakken JS, Richter P, Kimsey R, Madigan JE.
Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia.
J Clin Microbiol 1995;33:1098-103.

Dumler JS, Dawson JE, Walker DH.
Human ehrlichiosis: hematopathology and immunohistologic detection of Ehrlichia chaffeensis.
Hum Pathol 1993; 24: 391-96.

Dumler JS, Trigiani ER, Bakken JS, Aguero-Rosenfeld ME, Wormser GP.
Serum cytokine response during acute human granulocytic ehrlichiosis.
Clin Diagn Lab Immunol 2000 7:6-8

Dumler JS.
Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR.
J Clin Microbiol 1995; 33: 2710-14.

Dumler JS, Sutker WL, Walker DH.
Persistent infection with Ehrlichia chaffeensis.
Clin Infect Dis 1993 17: 903-05.

Dumler JS, Bakken JS:
Ehrlichial diseases of humans: Emerging tick-borne infections.
Clin Infect Dis 20:1102-1110, 1995.

Fichtenbaum CJ, Peterson LR, Weil GJ.
Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome.
Am J Med 1993; 95: 351-57.

Fishbein DB, Dawson JE, Robinson LE.
Human ehrlichiosis in the United States, 1985 to 1990.
Ann Intern Med 1994; 120: 736-43.

Fishbein DB, Kemp A, Dawson JE, Greene NR, Redus MA, Fields DH.
Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients.
J Infect Dis 1989; 160: 803-09.


Fordham LA, Chung CJ, Specter BB, Merten DF, Ingram DL.
Ehrlichiosis: findings on chest radiographs in three pediatric patients.
AJR Am J Roentgenol 1998; 171: 1421-24.


Goodman, J.L.
Ehrlichiosis -- Ticks, Dogs, and Doxycycline.
The New England Journal of Medicine -- July 15, 1999 -- Vol. 341, No. 3


Goodman JL, Nelson C, Vitale B, et al.
Direct cultivation of the causative agent of human granulocytic ehrlichiosis.
N Engl J Med 1996; 334:209-215


Hardalo CJ, Quagliarello V, Dumler JS.
Human granulocytic ehrlichiosis in Connecticut: report of a fatal case.
Clin Infect Dis 1995; 21: 910-14


Hodzic E, Fish D, Maretzki CM, de Silva AM, Feng S, Barthold SW.
Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks.
Infect Immun. J. Clin Microbiol 1998;36:3574-8.


Horowitz HW, Hsieh TC, Aguero-Rosenfeld ME, Kalantarpour F, Chowdhury I, Wormser GP, Wu JM.
Antimicrobial susceptibility of Ehrlichia phagocytophila.
Antimicrob Agents Chemother 2001 Mar;45(3):786-8


Horowitz HW, Marks SJ, Weintraub M, Dumler JS.
Brachial plexopathy associated with human granulocytic ehrlichiosis.
Neurology 1996; 46: 1026-29.


Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al.
The clinical and laboratory spectrum of culture proven human granulocytic ehrlichiosis: comparison with culture negative cases.
Clin Infect Dis 1998; 27: 1314-17.


Jahangir A, Kolbert C, Edwards W, Mitchell P, Dumler JS, Persing DH.
Fatal pancarditis associated with human granulocytic ehrlichiosis in a 44-year-old man.
Clin Infect Dis 1998; 27: 1424-27.


Klein MB, Nelson CM, Goodman JL.
Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis:promising activity of quinolones and rifamycins.
Antimicrob Agents Chemother 1997; 41: 76-79.


Klein MB, Hu S, Chao CC, Goodman JL.
The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines.
J Infect Dis 2000; 182: 200-05.


Lepidi H, Bunnell JE, Martin ME, Madigan JE, Stuen S, Dumler JS.
Comparative pathology and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections.
Am J Trop Med Hyg 2000; 62 29-37.


Lotric-Furlan S, Petrovec M, Avsic-Zupanc T, et al.
Human ehrlichiosis in central Europe.
Wien Kli Wochenschr 1998; 110: 894-97.


MacLeod JR, Gordon WS.
Studies in tick-borne fever of sheep. I. Transmission by the tick, Ixodes ricinus, with a description of the disease produced.
Parsitology 1933; 25: 273-85.


McDade J.
Ehrlichiosis: A disease of animals and humans.
Journ of Inf Dis 161: 509-617; 1990.


McQuiston JH, Paddock CD, Holman RC, Childs JE.
The human ehrlichioses in the United States.
Emerg Infect Dis 1999; 5: 635-42.


Maeda K, Markowitz N, Hawley RC, et al:
Human infection with Ehrlichia canis, a leukocytic rickettsia.
N Engl J Med 316:853-856, 1987.


Magnarelli LA, Dumler JS, Anderson JF, Johnson RC, Fikrig E.
Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera.
J Clin Microbiol. 1995;33:3054-3057.


Magnarelli LA, Stafford KC III, Mather TN, Yeh M-T, Martin ME, Bunnell JE, Dumler JS.
Pathology, immunohistology, and cytokine responses in early phases of HGE in a murine model.
J Infect Dis 2000;181:374-78


Martin GS, Christman BW, Standaert SM.
Rapidly fatal infection with Ehrlichia chaffeensis.
N Eng J Med 1999; 341: 763-64.


Oteo JA, Blanco JR, Martinez de Artola V, Ibarra V.
First Report of Human Granulocytic Ehrlichiosis from Southern Europe (Spain)
Emerg Infect Dis. 2000 Jul-Aug;6(4):430-2.


Paddock CD, Olson JG.
Rickettsial and ehrlichial infections.
National Center for Infectious Diseases, Centers for Disease Control and Prevention; 1999:166-169


Paddock CD, Sumner JW, Shore GM, et al.
Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis.
J Clin Microbiol 1997; 35: 2496-502.


Paddock CD, Suchard DP, Grumbach KL, et al.
Brief report: fatal seronegative ehrlichiosis in a patient with HIV infection.
N Engl J Med 1993; 329: 1164-67.


Peters TR, Edwards KM, Standaert SM.
Severe ehrlichiosis in an adolescent taking trimethoprim-sulfamethoxazole.
Pediatr Infect Dis J 2000; 19: 170-71.


Ratnasamy N, Everett ED, Roland WE, McDonald G, Caldwell CW.
Central nervous system manifestations of human ehrlichiosis.
Clin Infect Dis 1996; 23: 314-19.


Ravyn MD, Goodman JL, Kodner CB, et al.
Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.
J Clin Microbiol 1998; 36: 1480-88.


Ravyn M, Korenberg E, Oeding J, Kovaleskii Y.
Monocytic Ehrlichia in Ixodes persulcatus ticks from Perm, Russia.
Lancet 1999; 353: 722-23.


Reed KD, Mitchell PD, Persing DH, Kolbert CP, Cameron V
Transmission of human granulocytic ehrlichiosis [letter; comment].
JAMA 1995;273:23.


Rikihisa Y.
Clinical and biological aspects of infection caused by Ehrlichia chaffeensis.
Microbes Infect 1999; 1: 367-76.


Schutze GE, Jacobs RF.
Human monocytic ehrlichiosis in children.
Pediatrics 1997; 100: E10.


Schwartz I, Fish D, Daniels TJ.
Prevalence of the rickettsial agent of human granulocytic ehrlichiosis in ticks from a hyperendemic focus of Lyme disease.
N Engl J Med 1997;337:49-50.


Shea KW, Calio AJ, Klein NC, Cunha BA.
Ehrlichia equi infection associated with rhabdomyolysis.
Clin Infect Dis 1996; 22: 605.


Shibata S-I, Kawahara M, Rikihisa Y, et al.
New Ehrlichia species closely related to Ehrlichia chaffeensis isolated from Ixodes ovatus ticks in Japan.
J Clin Microbiol 2000; 38: 1331-38.


Standaert SM, Dawson JE, Schaffner W, et al.
Ehrlichiosis in a golf-oriented retirement community.
N Engl J Med 1995; 333: 420-25.


Standaert SM, Yu T, Scott MA, et al.
Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics.
J Infect Dis 2000; 181: 1082-88.


Telford SR, Dawson JE, Katavolos P, Warner CK, Kolbert CP, Persing DH.
Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.
Proc Natl Acad Sci USA 1996; 93: 6209-14.


Trofe J, Reddy KS, Stratta RJ, Flax SD, Somerville KT, Alloway RR, Egidi MF, Shokouh-Amiri MH, Gaber AO.
Human granulocytic ehrlichiosis in pancreas transplant recipients.
Transpl Infect Dis 2001 Mar;3(1):34-39


Walker DH, Dumler JS:
Emergence of the ehrlichioses as human health problems.
Emerg Infect Dis 2:18-28, 1996.


Walker DH and the working group.
Diagnosing human ehrlichioses: current status and recommendations.
ASM News 2000; 66: 287-90.


Wen B, Rikihisa Y, Mott J, Fuerst PA, Kawahara M, Suto C.
Ehrlichia muris sp.nov., identified on the basis of 16S rRNA base sequences and serological, morphological, and biological characteristics.
Int J Syst Bact 1995; 45: 250-54.


Weinstein RS.
Human ehrlichiosis.
Am Fam Physician 1996 Nov 1;54(6):1971-6


Williams JD, Snow RM, Arciniegas JG.
Myocardial involvement in a patient with human ehrlichiosis.
Am J Med 1995; 98: 414-15.


Zeidner NS, Burkot TR, Massung R, et al.
Transmission of the agent of human granulocytic ehrlichiosis by Ixodes spinipalpis ticks: evidence of an enzootic cycle of dual infection with Borrelia burgdorferi in Northern Colorado.
J Infect Dis 2000; 182: 616-19.


Yevich SJ, Sanchez JL, DeFraites RF, et al.
Seroepidemiology of infections due to spotted fever group rickettsiae and Ehrlichia species in military personnel exposed to areas of the United States where such infections are endemic.
J Infect Dis 1995; 171: 1266-73.


Yu X-J, McBride JW, Zhang XF, Walker DH.
Characterization of the complete transcriptionally active Ehrlichia chaffeensis 28-kDa outer membrane protein multigene family.
Gene 2000; 248: 59-68.


Yu X-J, Crocquet-Valdes PA, Cullman LC, Popov VL, Walker DH.
Comparison of Ehrlichia chaffeensis recombinant proteins for serologic diagnosis of human monocytotropic ehrlichiosis.
J Clin Microbiol 1999; 37: 2568-75.